印度: 重磅!新冠有救了印度病例狂降靠這

Oxford scientists to study ivermectin's efficacy for Covid treatment#coronavirus https://t.co/GcDm3Tghyt

— Business Standard (@bsindia) June 23, 2021

For context, I'm referring to this study: https://t.co/uktInFEvOR

"University of Oxford scientists are trialling giving Ivermectin to people with Covid symptoms to see if it can keep them out of hospital."

— Matt Donaldson (@MattSDonaldson) June 23, 2021

***BIG BREAKING NEWS*** India’s Ministry of Health issues new guidance for home isolation. It is now recommending a 3-5 day course of #ivermectin for asymptomatic or mild COVID-19 disease.

Water for the fire. https://t.co/Agg8JHw793

— Frontline Covid-19 Critical Care (@Covid19Critical) April 30, 2021

The All India Institute of Medical Sciences and Indian Council of Medical Research (ICMR) have issued new guidelines to identify #Covid19 treatment based on three levels of seriousness--mild, moderate and severe.

A look at the new protocol. pic.twitter.com/41lIS5oa7b

— Hindustan Times (@htTweets) April 24, 2021

COVID-19：イベルメクチンの鼻腔用スプレー登場（動畫）：　 Finnish Biotech Secures U.S. Patent for Ivermectin-based Nasal Spray：　 COVID-19：伊維菌素鼻噴劑出現：Therapeutica Borealis pic.twitter.com/7OjxgMYr8I

— Tokio X'press (@tokiox_ja) June 9, 2021